Morgan Stanley 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 4:55 pm Sale | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | MORGAN STANLEY MS | 1,319,809 1.700% | -2,832,637 (-68.22%) | Filing |
| 2024-02-09 10:33 am Purchase | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | MORGAN STANLEY MS | 4,152,446 5.500% | 4,152,446 (New Position) | Filing |